Cardlytics Stock Highlights Today's Bullish Analyst Attention

Analysts are also bullish on UPS, DPZ, and AKAM

Mar 6, 2018 at 10:48 AM
facebook twitter linkedin


Cardlytics Inc (NASDAQ:CDLX) is enjoying a round of bullish analyst attention following the expiration of its quiet period, as the company went public back on Feb. 9. At least four brokerage firms initiated coverage on CDLX stock with the equivalent of a "buy" rating, and SunTrust Robinson set the highest price target at $25. Meanwhile, the lowest mark was $21 from Raymond James. The equity is trading up 3.3% at $17.35 so far today.

Cardlytics' initial public offering (IPO) was priced at $13 per share, and the stock opened at $12.10. It traded as high as $20.99 back on Feb. 26, while its closing high is $18.82 from the day before. The company engages in what's called "purchase intelligence," providing consumer purchasing data for marketers and financial institutions.

UPS, DPZ, AKAM Stocks Also Enjoy Bull Notes

Checking in on some other analyst updates this morning, United Parcel Service, Inc.(NYSE:UPS) is again in the crosshairs after Stifel upgraded the stock to "buy." The brokerage firm said it believes UPS shares are oversold, presenting a prime buying opportunity for investors.

Baird weighed in on Domino's Pizza, Inc. (NYSE:DPZ) with an "outperform" rating and $260 price target. DPZ shares were last seen trading up 1.1% at $221.98.

And rounding out the analyst coverage this morning, Akamai Technologies, Inc. (NASDAQ:AKAM) got a price-target hike to $85 from $80 at Deutsche Bank. The shares already today tapped a fresh annual high of $70.70 as they continue to outperform on the charts.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial
 


 


 
Special Offers from Schaeffer's Trading Partners